Skip to main content
Category

News Archive

tedco-3-logo

TEDCO 2016 ICE Awards Winners

By News Archive

tedco-3-logo

And the Winners are…

Innovation

  • Cobrain
  • MFFire
  • Sisu Global Health

Corporate Excellence

  • Immunomic

Entrepreneur

  • Jess Gartner CEO and Founder, Allovue

Please join TEDCO at our annual ICE Awards, as we honor some of our “coolest” portfolio companies and recognize the best and brightest that are developing cutting-edge technologies and enriching our community.

Meet with 20 of TEDCO’s recently funded startup companies that will be exhibiting.

Network with the hottest tech startups, investors and entrepreneurship community in Maryland.

Read More
heritage-group-logo

Healthcare groups pool funds to find digital health innovators

By News Archive

heritage-group-logo

Investment firm Heritage Group has closed its second innovation fund and now counts 15 healthcare organizations as limited partners.

The $220 million fund is the latest example of how health systems and other industry players are taking an active role in piloting, investing in and mentoring young digital health companies as technology continues to reshape healthcare delivery. It is among the largest pools of funds for healthcare technology investments, and the combined approach allows the group to make larger investments in later-stage companies than they might otherwise do on their own.

Read More
johns-hopkins-logo

Top vaccine researcher sets sights on Zika – Technical.ly Baltimore

By News Archive

johns-hopkins-logo

Baltimore was a major site in the effort to develop an Ebola vaccine. Two years later, a leading Johns Hopkins researcher is looking to apply a major discovery to the Zika virus.

J. Thomas August, a JHU pharmacology and molecular sciences professor, formed Pharos Biologicals in December. The company received a license to develop DNA vaccine technology called the LAMP for influenza and flaviviruses from the Johns Hopkins School of Medicine.

Read More
GlaxoSmithKline-gsk-logo

GSK CEO: Big pharma should keep investing in R&D

By News Archive

GlaxoSmithKline-gsk-logo

GlaxoSmithKline CEO Andrew Witty attributes the company’s success to sticking to the tried-and-true business model of investing in research and development and not transitioning to an acquisition model.

Witty told CNBC’s “Closing Bell” on Monday that the key is to be patient and to see the value of investing in innovation.

Read More
mit-logo

This MIT employee redefined how universities launch startups

By News Archive

mit-logo

Lita Nelsen is one of the most influential power brokers in the drug industry — and yet there’s a good chance you’ve never heard of her.

That’s because she ran one of the country’s largest and most successful technology transfer offices, an unglamorous yet essential go-between for universities and startups. And any time a venture capitalist, a pharmaceutical company, or a tech titan wanted to cash in on an invention at the Massachusetts Institute of Technology, each had to go through her.

Read More
nih-logo

When Government Tried March In Rights To Control Health Care Costs – IPWatchdog.com

By News Archive

nih-logo

As we await the decision from the National Institutes of Health (NIH) on the petition backed by Senator Bernie Sanders (D-VT) and others urging that the march in provision of the Bayh-Dole Act be used to control drug prices, it’s worthwhile to recall the time the agency followed similar advice. That resulted in a smack down by Congress and the courts after a band of universities, an innovative small company and a conscientious federal employee refused to be bullied, altering the course of government.

Read More
innovation-into-action-logo

Innovation Into Action Challenge: Finalist Reception

By News Archive

innovation-into-action-logo

Thursday, May 26, 2016

Please join us for the award ceremony where we announce the three winners of the Innovation into Action Challenge—a new initiative to support innovations with the potential to make a difference in the lives of people in emerging nations. At stake is a tailored package of support designed to accelerate the winning innovations’ deployment in the field, including $100,000 in funding, market testing on DAI’s overseas projects, access to a network of accelerator professionals, and technical mentoring to refine the innovator’s pitch, product, or service.

Read More
Universities-at-Shady-Grove-logo

USG Executive Director Stewart Edelstein Releases Statement on Governor Hogan’s Reinstatement of Funding for BSE Facility

By News Archive

Universities-at-Shady-Grove-logo

Today, Stewart Edelstein, executive director of the Universities at Shady Grove, released the following statement:

“On behalf of the entire Universities at Shady Grove (USG) community, I want to thank the Maryland General Assembly and Governor Hogan for reinstating $36.7 million in funding for the construction of our Biomedical Sciences and Engineering Education (BSE) facility. With this secured funding, the Universities at Shady Grove plans to break ground later this year on the new facility.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.